U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of Medical Products and Tobacco
  5. Center for Drug Evaluation and Research
  6. Division of Oncology Products 1 (DOP1)
  1. Office of Medical Products and Tobacco

Division of Oncology Products 1 (DOP1)

Division of Oncology Products 1 (DOP1)

The Division of Oncology Products 1 (DOP1) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for breast, gynecologic, and genitourinary cancers, as well as supportive care (non-hematologic) products.

Management Team

Director: Julia A. Beaver, MD
Deputy Director: Amna Ibrahim, MD
Deputy Director for Safety: Katherine Fedenko, MS, CRNP
Associate Director of Labeling: William Pierce, PharmD
Chief Project Management Staff: Christy Cottrell
Chief Project Management Staff: Alice Kacuba, RN, MSN
Project Specialist: Dolores Bowen'

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Oncology Products 1 (DOP1)
5901-B Ammendale Road
Beltsville, MD 20705-1266

Phone: (301) 796-2330
Fax: (301) 796-9845

 

ResourcesForYou